Kezar Life Sciences, Inc.

This study tested an experimental drug called KZR-616 in 69 people with lupus, some of whom also had lupus-related kidney disease (lupus nephritis). The goal was to see if the drug is safe and can help control the disease by reducing protein in the urine, a sign of kidney damage.…

This study looked at the long-term safety and effectiveness of a drug called KZR-616 in 18 adults with active polymyositis or dermatomyositis, rare diseases that cause muscle inflammation and weakness. Participants had already completed a previous study and continued taking KZR-6…

This study tested an experimental drug called KZR-616 in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received weekly injections of the drug or a placebo for 16 weeks, then switched to the other…

This study tested a new drug called zetomipzomib in 24 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. Participants received either the drug or a placebo alongside their usual treatment for 24 weeks, with an option to continue the drug for…